Biology and Life Sciences

In 2025, strengthen your gut to protect against superbugs by adding prebiotic-rich foods like fermented dishes and fibre to your diet, supported by global agreements to reduce antibiotic overuse—this is your main plan for staying healthy in a world with antibiotic resistance.

In 2025, strengthen your gut to protect against superbugs by adding prebiotic-rich foods like fermented dishes and fibre to your diet, supported by global agreements to reduce antibiotic overuse—this is your main plan for staying healthy in a world with antibiotic resistance.

As superbugs threaten a $2 trillion annual economic hit by 2050, 2025 calls for updating the US National Action Plan for Combating Antibiotic-Resistant Bacteria (NAPCARB) with bold strategies—from farm antibiotic bans to AI surveillance—to avert catastrophe and save millions of lives.

In 2026, antimicrobial resistance (AMR) infects 1 in 6 people—fight back with this guide to ecological policies curbing farm overuse and home remedies like probiotic ferments that restore balance, saving lives amid a projected 10 million annual deaths.

In 2025, superbugs like MRSA and CRE threaten 10 million lives yearly—arm yourself with this survival guide to rational antibiotic use, from when to say no to prescriptions to community-led prevention tactics that cut resistance by 30% and safeguard your future.

The One Health revolution in 2025 is transforming global policy, slashing farm antibiotic use by up to 50% through EU mandates and UN initiatives, directly combating antimicrobial resistance (AMR), and averting millions of human deaths from superbugs.

In 2026, superbugs like MRSA and CRE claim 1.27 million lives yearly—fight back with these five science-backed lifestyle hacks, from probiotic-packed meals to AI-assisted hygiene, to safeguard your health in an era of rising resistance.

In December 2025, WHO's Variant Watch program monitors new risks from HPV lineage changes to TB vaccine advancements, managing a changing world of germs with genetic tracking and faster ways to ensure fair access.

As H3N2's subclade K surges in December 2025, evading immunity with seven mutations, this guide explains its razor-throat symptoms, rapid spread across 34 countries, and vaccine mismatch risks for a potentially brutal 2026 season—armed with prevention tactics.

As mRNA technology moves past COVID-19, Moderna's Phase 3 trial for a bird flu vaccine in 2025 shows how quickly we can respond, matching CEPI's goal to deliver pandemic vaccines within 100 days of identifying a threat—changing the way we protect global health

As December 2025 closes, Omicron subvariants XFV, NW.1, and LF.7 are gaining traction, comprising up to 20% of cases in key regions. This nowcast analyzes their rise, mutation profiles, and influence on 2026 COVID vaccine formulations, with CDC and WHO data guiding preparedness.

Scripps Research's innovative nanoparticle vaccines for Ebola and filoviruses, announced on December 18, 2025, use particles that mimic the virus to trigger strong immune responses against different strains, providing a hopeful new way to protect